Adaptive Biotechnologies Corporation Share Price
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 28.61 USD | +0.21% |
|
+18.22% | +76.17% |
| 08-20 | Adaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing | MT |
| 07-30 | Adaptive Biotechnologies Q2 Loss Widens, Revenue Rise | MT |
| Market Cap | 4.57B 3.98B 3.76B 3.41B 6.4B 438B 6.42B 45.03B 17.38B 223B 17.15B 16.77B 717B | P/E 2026 * |
-52.5x | P/E 2027 * | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.51B 3.93B 3.71B 3.37B 6.31B 432B 6.34B 44.45B 17.15B 220B 16.93B 16.55B 707B | EV / Sales 2026 * |
15.4x | EV / Sales 2027 * | 12.4x |
| Free-Float |
97.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
|
Boerse Muenchen
| 1HM | Real-time | |
|
Deutsche Boerse AG
| 1HM | Delayed | |
|
Tradegate
| 1HM | Real-time | |
|
Börse Stuttgart
| 1HM | Delayed |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | +0.21% | ||
| 1 week | +18.22% | ||
| Current month | +14.81% | ||
| 1 month | +16.49% | ||
| 3 months | +63.21% | ||
| 6 months | +115.44% | ||
| Current year | +76.17% |
| 1 week | 23.96 |  | 28.72 |
| 1 month | 23.53 | | 28.72 |
| Current year | 12 | | 28.72 |
| 1 year | 12 | | 28.72 |
| 3 years | 2.28 | | 28.72 |
| 5 years | 2.28 | | 39.62 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 07/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 07/04/2024 |
Julie Rubinstein
PSD | President | 54 | 31/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 31/01/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 30/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Don | Director | -12,539 | 0.0079% | ||
| 26/08/26 | Sell | Director | -9,615 | 0.0060% | ||
| 18/08/26 | Exercice | Director | 60,664 | 0.0379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | +18.22% | +107.77% | +418.30% | 4.56B | |
| +2.30% | +19.19% | +365.91% | +72.85% | 4.54B | |
| -1.91% | -2.63% | +19.76% | +63.56% | 3.26B | |
| -0.83% | +7.10% | +264.45% | +580.53% | 2.81B | |
| +6.41% | +10.68% | -22.23% | -26.21% | 2.14B | |
| +10.59% | +13.36% | +54.41% | - | 1.75B | |
| +0.30% | +7.13% | +30.00% | +48.90% | 1.11B | |
| -4.13% | +6.74% | +142.01% | -31.13% | 1.08B | |
| -3.88% | -4.48% | -19.42% | +37.28% | 594M | |
| +2.98% | +4.96% | -31.54% | -22.06% | 515M | |
| Average | +1.20% | +7.65% | +91.11% | +126.89% | 2.24B | |
| Weighted average by Cap. | +1.35% | +10.52% | +141.63% | +196.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 256M 241M 219M 411M 28.14B 412M 2.89B 1.12B 14.31B 1.1B 1.08B 46.03B | 359M 313M 295M 268M 502M 34.4B 504M 3.54B 1.36B 17.49B 1.35B 1.32B 56.28B |
| Net income | -85.78M -74.8M -70.63M -64.14M -120M -8.23B -121M -846M -326M -4.18B -322M -315M -13.46B | -27.55M -24.03M -22.69M -20.6M -38.6M -2.64B -38.76M -272M -105M -1.34B -103M -101M -4.32B |
| Net Debt | -58.99M -51.44M -48.57M -44.11M -82.64M -5.66B -82.99M -582M -225M -2.88B -222M -217M -9.26B | -104M -90.54M -85.49M -77.63M -145M -9.96B -146M -1.02B -395M -5.07B -390M -381M -16.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | US$28.61 | +0.21% | 2,985,535 |
| 17/09/26 | US$28.55 | +3.18% | 3,279,757 |
| 16/09/26 | US$27.67 | +3.71% | 5,026,486 |
| 15/09/26 | US$26.68 | +7.67% | 4,124,280 |
| 14/09/26 | US$24.78 | +2.40% | 1,730,383 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
